JP2024533093A5 - - Google Patents

Info

Publication number
JP2024533093A5
JP2024533093A5 JP2024513469A JP2024513469A JP2024533093A5 JP 2024533093 A5 JP2024533093 A5 JP 2024533093A5 JP 2024513469 A JP2024513469 A JP 2024513469A JP 2024513469 A JP2024513469 A JP 2024513469A JP 2024533093 A5 JP2024533093 A5 JP 2024533093A5
Authority
JP
Japan
Prior art keywords
cells
nkt
nkp44
subject
itcr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024533093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/042147 external-priority patent/WO2023034377A1/en
Publication of JP2024533093A publication Critical patent/JP2024533093A/ja
Publication of JP2024533093A5 publication Critical patent/JP2024533093A5/ja
Pending legal-status Critical Current

Links

JP2024513469A 2021-09-01 2022-08-31 リンパ球集団およびその産生方法 Pending JP2024533093A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163239566P 2021-09-01 2021-09-01
US63/239,566 2021-09-01
PCT/US2022/042147 WO2023034377A1 (en) 2021-09-01 2022-08-31 Lymphocyte population and methods for producing same

Publications (2)

Publication Number Publication Date
JP2024533093A JP2024533093A (ja) 2024-09-12
JP2024533093A5 true JP2024533093A5 (cg-RX-API-DMAC7.html) 2025-09-08

Family

ID=83447808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513469A Pending JP2024533093A (ja) 2021-09-01 2022-08-31 リンパ球集団およびその産生方法

Country Status (8)

Country Link
US (1) US20240358829A1 (cg-RX-API-DMAC7.html)
EP (1) EP4395784A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024533093A (cg-RX-API-DMAC7.html)
KR (1) KR20240055044A (cg-RX-API-DMAC7.html)
CN (1) CN118302171A (cg-RX-API-DMAC7.html)
CA (1) CA3229529A1 (cg-RX-API-DMAC7.html)
IL (1) IL311041A (cg-RX-API-DMAC7.html)
WO (1) WO2023034377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021035078A1 (en) * 2019-08-21 2021-02-25 Akeso Therapeutics, Inc. Type iii nkt cells and related compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015112793A2 (en) * 2014-01-27 2015-07-30 St. Jude Children's Research Hospital, Inc. Methods of expanding ex vivo natural killer t (nkt) cells and therapeutic uses thereof
CN110475571B (zh) 2017-04-01 2023-04-04 Avm生物技术有限责任公司 细胞免疫疗法前细胞毒性预调理的替代
EP3488851A1 (en) 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies
KR20220148859A (ko) * 2020-02-28 2022-11-07 에이브이엠 바이오테크놀로지, 엘엘씨 림프구 집단 및 이를 생산하는 방법
WO2021247000A1 (en) 2020-06-01 2021-12-09 Avm Biotechnology, Llc Methods of treatment using icam-modulating agents

Similar Documents

Publication Publication Date Title
CN112912494B (zh) γ-δT细胞和自然杀伤细胞的治疗制剂以及制造和使用方法
DE102017127984B4 (de) Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
Smith et al. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin‐4 production and associated eosinophilia
JP2020518289A5 (cg-RX-API-DMAC7.html)
JP2022002517A (ja) 非造血組織常在性γδ T細胞の増幅および該細胞の使用
EP1390474B1 (fr) Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
Čolić et al. Interleukin‐17 plays a role in exacerbation of inflammation within chronic periapical lesions
Gordon et al. Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells
Morris et al. Advances in the understanding of acute graft‐versus‐host disease
CN107177548B (zh) 一种体外扩增淋巴细胞的培养体系及扩增方法和应用
EP3419657A1 (en) Whole-cell cancer vaccines and methods for selection thereof
EP2493485A1 (en) Use of autologous effector cells for treatment of multiple myeloma
JP2024513958A5 (cg-RX-API-DMAC7.html)
Meinl et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques
JP2023514788A5 (cg-RX-API-DMAC7.html)
JP2024513522A5 (cg-RX-API-DMAC7.html)
US20250255907A1 (en) Extracellular vesicles isolated from stem cells, and uses thereof
JP2001149069A (ja) ナチュラルキラー細胞の増殖方法
WO2018013589A1 (en) Methods and compositions for thymic transplantation
EP4511056A2 (en) Allogeneic t cells for treatment of hematological malignancies
JP2022513587A (ja) 造血幹細胞移植後の回復を実施および促進するための改善
WO2018013585A1 (en) Methods and compositions for modulating thymic function
EP0305468A1 (en) B-cell growth and differentiating factor BCGF 12K for use in therapy
CA3168378A1 (en) Lypmphocyte population and methods for producing same
US20060093580A1 (en) Tolerogenic vaccine and method